Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids-Reference-Cited by-同舟云学术

Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids

Published:2013-01-30 Issue:6 Volume:52 Page:1058-1069
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Devogelaer J.-P.,Sambrook P.,Reid D. M.,Goemaere S.,Ish-Shalom S.,Collette J.,Su G.,Bucci-Rechtweg C.,Papanastasiou P.,Reginster J.-Y.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/52/6/1058/5198208/kes410.pdf

Reference44 articles.

1. The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results

2. Glucocorticoid-Induced Osteoporosis: Mechanisms and Therapeutic Approach

3. The epidemiology of glucocorticoid-associated adverse events

4. Bone fragility in male glucocorticoid-induced osteoporosis is not defined by bone mineral density

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient preference, efficacy, and compliance with zoledronic acid for glucocorticoid-induced osteoporosis in patients with autoimmune diseases;Postgraduate Medical Journal;2024-01-31

2. Biochemical markers of bone turnover in osteoporosis;Marcus and Feldman's Osteoporosis;2021

3. Zoledronate;Bone;2020-08

4. Effect of Zoledronic Acid and Denosumab in Patients With Low Back Pain and Modic Change: A Proof-of-Principle Trial;Journal of Bone and Mineral Research;2018-02-02

5. Prevention and treatment of glucocorticoid-induced osteoporosis;Racionalna terapija;2018